Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2010; 16(47): 5975-5981
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5975
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5975
Figure 1 Expression of cyclooxygenase-2 in normal esophageal mucosa and esophageal squamous cell carcinoma.
Positive staining in cytoplasm in normal mucosa (A), well-differentiated squamous cell carcinoma (SCC) (B) and poorly-differentiated SCC (C). Counterstaining with hematoxylin, × 200.
Figure 2 Expression of Ki-67 in normal esophageal mucosa and esophageal squamous cell carcinoma.
Positive nuclei staining in normal esophageal mucosa (A, × 100), well-differentiated (B, × 200) and poorly-differentiated squamous cell carcinoma (C, × 200). Counterstaining with hematoxylin.
Figure 3 Expression of cyclin A in normal esophageal mucosa and esophageal squamous cell carcinoma.
Positive nuclei staining in normal esophageal mucosa (A, × 100), well-differentiated (B, × 200) and poorly-differentiated squamous cell carcinoma (C, × 200). Counterstaining with hematoxylin.
Figure 4 Expression of p27 in normal esophageal mucosa and esophageal squamous cell carcinoma.
Sections stained with anti-p27 antibody showing nuclear staining (brown) in normal esophageal mucosa (A, × 100), well-differentiated (B, × 200) and poorly-differentiated squamous cell carcinoma (C, × 200). Counterstaining with hematoxylin.
- Citation: Huang JX, Xiao W, Chen WC, Lin MS, Song ZX, Chen P, Zhang YL, Li FY, Qian RY, Salminen E. Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2010; 16(47): 5975-5981
- URL: https://www.wjgnet.com/1007-9327/full/v16/i47/5975.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i47.5975